PME October 2026


Harnessing the power of social media for patient engagement; The next phase of oral GLP-1s; Incentivising new treatments for rare diseases


Explore how social media drives patient engagement, what’s next for oral GLP-1 drugs, and the incentives accelerating new rare disease treatments.

October 2026 - Pharmaceutical Market Europe

Pharmaceutical industry news, articles, jobs, reports, advice and services

Pharmaceutical Market Europe

PME – Pharmaceutical Market Europe is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

Using the power of social media
to break down obstacles preventing
improved patient engagement

A rare opportunity – developing new treatments for rare diseases

Oral GLP-1s – the three waves of innovation that pharma leaders should watch

Using the power of social media to break down obstacles preventingimproved patient engagement

A rare opportunity – developing new treatments for rare diseases

Oral GLP-1s – the three waves of innovation that pharma leaders should watch

Using the power of social media
to break down obstacles preventing
improved patient engagement